...
首页> 外文期刊>Applied Microbiology and Biotechnology >The biosynthesis of glycopeptide antibiotics—a model for complex, non-ribosomally synthesized, peptidic secondary metabolites
【24h】

The biosynthesis of glycopeptide antibiotics—a model for complex, non-ribosomally synthesized, peptidic secondary metabolites

机译:糖肽抗生素的生物合成-一种复杂的,非核糖体合成的,肽类次级代谢产物的模型

获取原文
获取原文并翻译 | 示例
           

摘要

Glycopeptide antibiotics are a class of widely known natural compounds produced by Actinomycetes. Vancomycin, the first member of the glycopeptide family to be discovered, was described in 1955 and used as an antibiotic soon thereafter. During the past 50 years numerous contributions on the structure, mode of action, and therapeutic features of vancomycin have been published. Recently, there has been considerable progress in elucidating the biosynthesis of glycopeptide antibiotics by combining molecular biology and analytical chemistry methods. Here, we provide an overview of the current knowledge regarding biosynthetic glycopeptide assembly.
机译:糖肽抗生素是放线菌产生的一类广泛已知的天然化合物。万古霉素是发现的糖肽家族的第一个成员,于1955年被描述并在此后不久用作抗生素。在过去的50年中,已发表了有关万古霉素的结构,作用方式和治疗特征的众多文章。近来,通过结合分子生物学和分析化学方法在阐明糖肽抗生素的生物合成方面取得了相当大的进展。在这里,我们提供了有关生物合成糖肽组装的最新知识的概述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号